{"ticker": {"uuid": "55a892cf-f4c5-4d31-b988-4c0c201a095e", "symbol": "LNAI", "name": "Lunai Bioworks Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "$Lunai Bioworks (LNAI.US)$", "summary": "An investor expresses confidence in Lunai Bioworks (LNAI.US), stating that buyers will return and the stock will build momentum for a future run-up. The comment suggests an optimistic outlook for the company's stock performance. This short post is part of the moomoo Community fee", "url": "https://www.moomoo.com/community/feed/lunai-bioworks-lnai-us-no-worries-buyera-will-be-back-116762015301637", "source_name": "Moomoo", "published_at": "2026-06-17T22:39:45", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks touts defense revenue, neurology pipeline, lawsuit", "summary": "Lunai Bioworks' CEO has provided an update on the company's progress, highlighting its first revenue-generating U.S. defense contract through BioSymetrics, advancements in its Augusta AI neurology platform for epilepsy, Parkinson's, and Alzheimer's, and ongoing litigation against", "url": "https://www.stocktitan.net/news/LNAI/lunai-bioworks-ceo-letter-to-lu406oewjx95.html", "source_name": "Stock Titan", "published_at": "2026-06-17T22:39:45", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Lunai Bioworks Inc. Reports Material Event", "summary": "Lunai Bioworks Inc. (LNAI) filed an 8-K report detailing a material event, specifically the issuance of a letter to shareholders on June 17, 2026. This letter outlines the company's strategic advancements in biodefense and precision neurology, highlighted by a revenue-generating ", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-7f77a3d39d0e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:32:08", "published_display": "17 Jun 2026 20:32", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit", "summary": "Lunai Bioworks (LNAI) announced its first revenue-generating, multi-year U.S. defense collaboration with BioSymetrics for AI-enabled chemical threat assessment. The company also filed for expedited discovery in a lawsuit alleging naked short selling, citing evidence of 29.6 milli", "url": "https://www.tradingview.com/news/tradingview:4fcf7208c6092:0-lunai-bioworks-secures-first-revenue-defense-contract-files-expedited-discovery-in-naked-shorting-suit/", "source_name": "TradingView", "published_at": "2026-06-17T20:10:10", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/lunai-bioworks-ceo-letter-shareholders-131500365.html", "source_name": "PR Newswire", "published_at": "2026-06-17T13:15:00+00:00", "published_display": "17 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) Stock Soars 81% on Nasdaq Compliance Restoration", "summary": "Lunai Bioworks (LNAI) shares surged over 80% in after-hours trading after Nasdaq officially recognized the company's return to compliance with the $1.00 minimum bid price rule. While this restores their listing, the company now enters a strict one-year monitoring period where fal", "url": "https://blockonomi.com/lunai-bioworks-lnai-stock-soars-81-on-nasdaq-compliance-restoration/", "source_name": "Blockonomi", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNAI Stock Sees Volatile Spike As Traders Zero In On Risk", "summary": "Lunai Bioworks Inc Com (LNAI) stock experienced a volatile spike, trading up by 74.6% due to favorable biotech innovation news, despite weak financials. The company shows minimal revenue, significant operating losses, and a poor balance sheet, making it a high-risk, high-volatili", "url": "https://www.timothysykes.com/news/lunai-bioworks-inc-com-lnai-news-2026_06_17/", "source_name": "www.timothysykes.com", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNAI Stock Explodes On Volume As Traders Target Volatility", "summary": "Lunai Bioworks Inc (LNAI) stock surged by 61.16% on high volume, driven by positive sentiment and momentum trading despite poor fundamentals. The company reported minimal revenue, significant losses, and negative equity, making it a speculative play for short-term traders targeti", "url": "https://stockstotrade.com/news/lunai-bioworks-inc-com-lnai-news-2026_06_17/", "source_name": "StocksToTrade", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock jumps after Nasdaq bid-price compliance filing", "summary": "Lunai Bioworks shares surged after Nasdaq confirmed the company's compliance with the $1 minimum bid-price rule, a crucial step for maintaining its listing. Despite this, Lunai remains under a one-year Nasdaq panel monitor and faces ongoing capital needs, reporting a significant ", "url": "https://ts2.tech/en/lunai-bioworks-stock-jumps-after-nasdaq-bid-price-compliance-filing/", "source_name": "TechStock\u00b2", "published_at": "2026-06-17T12:42:08", "published_display": "17 Jun 2026 12:42", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | Lunai Bioworks Surges 151.66% Pre-Market", "summary": "Lunai Bioworks saw a significant surge of 151.66% in pre-market trading, driven by the announcement of an exclusive licensing agreement for its lead gene therapy program, LNAI-201, with Takeda Pharmaceutical. This agreement targets rare neurological genetic disorders, providing a", "url": "https://www.moomoo.com/news/post/71648509/trending-stocks-today-lunai-bioworks-surges-151-66-pre-market", "source_name": "Moomoo", "published_at": "2026-06-17T08:13:47", "published_display": "17 Jun 2026 08:13", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) Stock Is Trending Overnight \u2014 Here's Why It Spiked Nearly 81% In After-Hours Session", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdlNEOHpoV1dsMU5ESFZxUmMweDhaa0dRdnVYWXBWUW9wb0lyWWVXRVhZaXB6eTBuTXBmWk5kUU1UbzhoTFItMTQ2dnZ2MWI0TG5MLVVCbG1mSzBxWlV0UkNjbHAwRzNpNHBMM3VRejBlOXhvdWpuVlRILXVLSjZFXzRCNk4tRzA1Z1V3cjBIb2FXZUVqWG1wUkpkSTE4V3VKSTBWMXAybXdrZWJrXzBrUUIzZExLOS1qNVpUVERKX19NNlQtWkdZN05pMmRYVzd6Yzg0V0NjSzFyaGF1cVFvS2RhbDBqSzg?oc=5", "source_name": "Sahm", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Ord Shs (LNAI) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Lunai Bioworks Ord Shs (LNAI), presenting a list of major institutional shareholders and their shareholdings, including changes in their positions. Key shareholders like RS Group ApS and Lakysa Ventures, Inc. are hi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnai/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T03:40:47", "published_display": "17 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS INC (LNAI) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE9aWEYwQTFNSTF6S1IzV1Z3VmRVMVNERVAwd3Vsdmw1LXNPUnN0b3NHM1VFNmlFNVUzdFVtcHhudEN0aF9YT25TSnBQVXRPSFZqX1o5dzJld0dnVXl3VWUyTllWbGM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-17T00:20:49+00:00", "published_display": "17 Jun 2026 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai regains Nasdaq $1.00 bid-price compliance; one-year Panel monitoring imposed", "summary": "Lunai Bioworks (LNAI) has successfully regained compliance with Nasdaq's minimum $1.00 bid-price rule. As a result, the company will be subject to a mandatory one-year monitoring period by the Nasdaq Panel. During this monitoring period, if Lunai again violates the bid-price rule", "url": "https://www.tradingview.com/news/tradingview:c4b2c2190a296:0-lunai-regains-nasdaq-1-00-bid-price-compliance-one-year-panel-monitoring-imposed/", "source_name": "TradingView", "published_at": "2026-06-16T20:03:26", "published_display": "16 Jun 2026 20:03", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) back in bid compliance but under 1-year Nasdaq monitor", "summary": "Lunai Bioworks (LNAI) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, as confirmed by Nasdaq. The company will now be under a mandatory one-year monitoring period, during which any future non-compliance with the bid price rule will result i", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-8f8d1ba38ff9.html", "source_name": "Stock Titan", "published_at": "2026-06-16T19:59:25", "published_display": "16 Jun 2026 19:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Inc Stock Short Interest Rises to 62.94%", "summary": "Lunai Bioworks Inc (LNAI) saw its short interest increase to 62.94% of the float on May 15th, representing a 50.51% rise from April 30th. This means 2,489,634 shares were held short, and it would take an estimated 1.0 days for short sellers to cover their positions. Institutional", "url": "https://www.quiverquant.com/news/Lunai+Bioworks+Inc+Stock+Short+Interest+Rises+to+62.94%25", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T13:28:00", "published_display": "09 Jun 2026 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks partners with BrainStorm on neurology drug discovery", "summary": "Lunai Bioworks' subsidiary BioSymetrics has partnered with BrainStorm Therapeutics to identify and validate new treatments for neurological diseases, focusing initially on rare genetic epilepsies and neurodegenerative conditions like Parkinson's disease. The collaboration leverag", "url": "https://m.uk.investing.com/news/stock-market-news/lunai-bioworks-partners-with-brainstorm-on-neurology-drug-discovery-93CH-4702676?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-28T15:38:47", "published_display": "28 May 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI and human brain organoids join forces on Parkinson's, rare epilepsy", "summary": "Lunai Bioworks, through its subsidiary BioSymetrics, and BrainStorm Therapeutics have launched a collaboration to discover and validate therapeutic targets for neurological diseases like Parkinson's and rare genetic epilepsies. This partnership leverages AI target discovery, huma", "url": "https://www.stocktitan.net/news/LNAI/lunai-bioworks-and-brain-storm-therapeutics-launch-foundation-funded-yancj4z23x6l.html", "source_name": "Stock Titan", "published_at": "2026-05-28T14:10:25", "published_display": "28 May 2026 14:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration", "summary": "Lunai Bioworks and BrainStorm Therapeutics are collaborating to discover and develop novel therapies for neurological diseases, including Parkinson's and rare genetic epilepsies. The partnership, supported by a grant from the LouLou Foundation, combines BioSymetrics' AI-driven ta", "url": "https://www.prnewswire.com/news-releases/lunai-bioworks-and-brainstorm-therapeutics-launch-foundation-funded-parkinsons-and-rare-epilepsy-ai-discovery-collaboration-302784369.html", "source_name": "PR Newswire", "published_at": "2026-05-28T13:10:25", "published_display": "28 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pretax income of Lunai Bioworks, Inc. \u2013 LS:A42CL6", "summary": "This article displays the pretax income for Lunai Bioworks, Inc. (A42CL6), a biotechnology company listed on the Lang & Schwarz Tradecenter. The specific financial values are not provided within the snippet, but the article indicates it is a financial data point for the company. ", "url": "https://www.tradingview.com/symbols/LS-A42CL6/financials-income-statement/pretax-income/", "source_name": "TradingView", "published_at": "2026-05-28T11:10:25", "published_display": "28 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks, Inc. Cash Flow \u2013 LS:A42CL6", "summary": "This article provides key cash flow information for Lunai Bioworks, Inc. (A42CL6), indicating a free cash flow of -888.77K EUR for Q3 2026 and -6.68M EUR for the full year 2025, with operating cash flow also at -6.68M EUR for 2025. It presents a historical overview of cash from o", "url": "https://www.tradingview.com/symbols/LS-A42CL6/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-28T11:10:25", "published_display": "28 May 2026 11:10", "sentiment": "negative", "sentiment_pct": 16, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Company Profile & Introduction", "summary": "This document is a placeholder for the company profile and introduction of Lunai Bioworks. It indicates that further details about the company will be provided within this section.", "url": "https://www.moomoo.com/stock/LNAI-US/company?chain_id=Name1K9-3FXPhg.1kqk680&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A61,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Ffeed%2F106423782735877%22%7D", "source_name": "Moomoo", "published_at": "2026-05-26T23:40:51", "published_display": "26 May 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks, Inc. Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of Lunai Bioworks Inc.'s SEC filings and other financial documents. It includes various forms such as 10-K (Annual Report) and 10-Q (Quarterly Report), investor presentations, and event transcripts dating back to 2014. The information is", "url": "https://www.tradingview.com/symbols/BOATS-LNAI/documents/", "source_name": "TradingView", "published_at": "2026-05-24T19:40:23", "published_display": "24 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock", "summary": "A federal judge in Delaware has granted Lunai Bioworks, Inc.'s motion for expedited discovery to identify \"John Doe\" defendants involved in alleged \"naked\" short-selling of the company's common stock. This action seeks to hold those responsible accountable for securities fraud an", "url": "https://www.prnewswire.com/news-releases/federal-judge-orders-expedited-discovery-to-identify-john-doe-defendants-naked-short-sellers-of-lunai-common-stock-302779803.html", "source_name": "PR Newswire", "published_at": "2026-05-22T13:39:33", "published_display": "22 May 2026 13:39", "sentiment": "positive", "sentiment_pct": 81, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Announces 1-for-8 Reverse Stock Split", "summary": "Lunai Bioworks (LNAI) announced a 1-for-8 reverse stock split of its common shares, effective May 22, 2026, to restore compliance with Nasdaq's minimum bid requirement. This action will reduce outstanding shares from approximately 36.3 million to 4.5 million, with proportional ad", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2065173/lunai-bioworks-announces-1-for-8-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-05-21T13:41:04", "published_display": "21 May 2026 13:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock falls after reverse split announcement", "summary": "Lunai Bioworks Inc. (NASDAQ:LNAI) shares dropped 12.6% after announcing a 1-for-8 reverse stock split set to take effect on May 22, 2026. This move aims to increase the stock price to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The reverse sp", "url": "https://www.investing.com/news/stock-market-news/lunai-bioworks-stock-falls-after-reverse-split-announcement-93CH-4701556", "source_name": "Investing.com", "published_at": "2026-05-21T09:41:04", "published_display": "21 May 2026 09:41", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks to implement 1-for-8 reverse stock split", "summary": "Lunai Bioworks announced a 1-for-8 reverse stock split of its common stock, effective May 21, 2026. The company's ticker symbol \"LUNA\" will remain unchanged, but the CUSIP number will change to 55042D209. The reverse stock split aims to increase the per-share trading price to mee", "url": "https://www.msn.com/en-us/money/topstocks/lunai-bioworks-to-implement-1-for-8-reverse-stock-split/ar-AA23EOJs", "source_name": "MSN", "published_at": "2026-05-20T15:40:15", "published_display": "20 May 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock falls after reverse split announcement By Investing.com", "summary": "Lunai Bioworks Inc. (NASDAQ:LNAI) shares dropped 12.6% after announcing a 1-for-8 reverse stock split set to take effect on May 22, 2026. This action is intended to increase the stock price to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The r", "url": "https://ng.investing.com/news/stock-market-news/lunai-bioworks-stock-falls-after-reverse-split-announcement-93CH-2521616", "source_name": "Investing.com Nigeria", "published_at": "2026-05-20T14:34:00", "published_display": "20 May 2026 14:34", "sentiment": "negative", "sentiment_pct": 14, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) plans 1-for-8 reverse split to meet Nasdaq price rule", "summary": "Lunai Bioworks (NASDAQ: LNAI) announced a 1-for-8 reverse stock split, effective May 22, 2026, to regain compliance with Nasdaq's minimum bid price rule of $1.00 per share. This action will reduce outstanding shares from approximately 36.3 million to 4.5 million, with fractional ", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-4d2e5500620a.html", "source_name": "Stock Titan", "published_at": "2026-05-20T13:40:15", "published_display": "20 May 2026 13:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPUGRUTlJSd3dUSm1YS0JPZDNKVHlmMzVJdlVKUklaTW40czd0RFhSZVltRHo1MUpjT1JFTjVyYnBQZmoxclRqSHhWVFEzOWp1VE1EM01LYWJndVQ1LUpyQzJrNDR0ZVdpbUMtNlFRdldjalllX0p3ZnByVlVrcTF1Qml6MHpGSENZcnl3dnVBTTQtSnFzQ1FleGNLY01NbV96TS1CQThWaw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks: Fiscal Q3 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lunai-bioworks-fiscal-q3-earnings-210410094.html", "source_name": "Associated Press", "published_at": "2026-05-15T21:04:10+00:00", "published_display": "15 May 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lunai Bioworks shareholders approve reverse stock split and meeting adjournment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdW1HazRIRGJoaTlxclJvYXpyNTRCNDJYLU5vVTlZaHhTTFlTUTR6VEJwUlRaV0YtRjhzeEwwdjZkRF90SjhlY0xGdkFEa0lZUTBXUXVfVkY5MEZHRG5CRzVaN1U3U2lxc1lsUlYxMzhCbUwzX1UyS2hmaGZNVmFUTjVENWx2T3lfaWNNb0x6UjJsaDFyUzd3cU84WHFNYXdDNVZKV25ZQlBnZVBDUEJfTlI1YVg4aXNRUFJQVnZvSzR3OGFuMDFFQ00yZE9xU0hh?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) wins shareholder approval for reverse stock split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVk5tUG0zaFBaMDJEV080NXl3S2ZfWHp1RDE4LWhMY19LMldHc3B0NW1ubG80T2NiQ1p3RDhSTEMwZjQxNlhZamhFOTlaSnZhU1dlSlUzU3BHTW1aZjZaVUx3aTZqTHlWbmQwc1BaaVRPcEhnT1dLekx3bnR2RGNBajIwVWlGUUtXa0NoRXFZZ3FtUHg1ZTJrd2xwb0MwOTVBRWF4ZkVkcmg4RWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) warns of Nasdaq delisting risk after MVLS shortfall", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOOWRKbVloZ05ZQ1pEb21Gb0YwejZVWkcxZlEtei1RT0FBTktsSi1JREZtS1puXzZEQnVNZ1p0V0xTOVVsM050UnVyVzhqdjNzVjZiNUNmUWFjRElZbHhhSENycTFfVTZGUFA3VEZVQl8tZm1BU2JBaEFwVmNYU0twelBPQ2N5TXV6RVc2ZnhDd1BNRVYwZDhVWTRiX2lzOW5VbEdoZUxSR19qb1ltaG5Pa0c3SGowUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer\u2019s Disease", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oncotelic-therapeutics-announces-closing-strategic-123000748.html", "source_name": "GlobeNewswire", "published_at": "2026-05-06T12:30:00+00:00", "published_display": "06 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lunai-bioworks-completes-20-million-133500592.html", "source_name": "PR Newswire", "published_at": "2026-05-04T13:35:00+00:00", "published_display": "04 May 2026 13:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) issues $20M preferred to acquire CNS patents, aid Nasdaq equity test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQY1hZTk9VQzdYbEhuOWlMWVRPeG1JWFFoc21ndmRmNXQ2Mm1CczBLcmRLVUFoREFPT256UVhkSVZBTzg2Ump6bE5mZk5meE9nby1MdEtQYjVHVDVBWkkzYWlEempQVC1qSEcwamlwNjdwMkV4UmdBOUcxZi0xV01KYmtDbjlDRXlRNGt6dmJfaGxYRnFwajlHSUd0N01qUDhCc0tqeThTMFFVZzA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) files proxy supplement; Reverse Split on ballot", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPc29tM0g5RnhLQWNPWlM4QVd4Nmd1dloyYV93U2R2bXMtVFJHQ0ZUSUNLUkFoQlZidl9JUWRpajVxdFI0TDhLdXF5WUV5NGM3bU41MGkycVd1TmNYT3ZBWExkR09RRDJENHozdlJFMWl1ZzhBUHB1c0hrZTVKQmtEMTZpby1waDZBeVhvLU5aamxtX1BRdjNiNTI1ano0d2RGWF94MkRDU3NMajROZG52SDVB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) moves special vote to May 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQV2E0MVJkT1l1RDl3b3doQmRuTEVheUhvMEliNEg2UXFCdUxoNHhKa0tuVDFMa3hiME8ybjhJVjRiODFwUFNnNDZ3bHpleXN2SkNiQ3l4MHhBWi1sUENYMTNacnJDSHZlT09MczhqaElhX2tnTGRLSVJEUlZEbDVYQWN6YVgya2FqaTJ6cWRlX3BZWU91ZHl1Z3BCbURUZjRIOE9hcE9fTEVXN1k?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships", "summary": "", "url": "https://finance.yahoo.com/news/lunai-bioworks-nasdaq-lnai-geneial-131000127.html", "source_name": "PR Newswire", "published_at": "2026-04-15T13:10:00+00:00", "published_display": "15 Apr 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) seeks approval for wide-range reverse stock split to support Nasdaq listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxObG42eGlPbTI5OEZ4cTN4TV9QYWFKT2tmVE91YVVhcThlVmpQODNvbWNfSC1sRkhsTlg1VjE2eXB3TTVVSUxYZjUybi1aNElvaDFlaTJnOFE2LXNENGMwTFBUOXhlSlFzMERHMm5kT3FrdnBPa1FPVmtIem03VWJ3QW9Gejl5dmhhMWd0R2dCdjZ3SW8yV3JpN242b0pOZTZhdVJTYVhjcTYyUlo0bVNqVDlTWmF6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nasdaq moves to delist Lunai Bioworks (LNAI) after 30 days under $1", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNSi0xSDVad292bTNBQjZUZnUwN0o4NkNJZFEyNGxnVFh2cUVmYWNJNDZmYXB0T1RQN3Y0VGU5cEFBcmNfN2dvWVJTdGx0TlFVWUFrM1JkT1VBQW9ETFp0YTBxN0RyVE1VRlVIa2NWYmRsaTVRNGFvc2tDSDdvejJkTGIxLUN2eEJ6ZlJ0QXBSSmxvV3B0OS15TGRwTUpzczZrU3lrZmdtNTlIVXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI firm Lunai Bioworks targets 30M with poorly treated Alcohol Use Disorder", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQb2xDNV91Snl6WmZIclh0cDRWN0pGaFdSWXEtOURjZXJDUV8wc3FOWW00UmppRDYzaUh0WGdqX2hfdHRCYlV5eEw5WW9vUmQ3bE9OVXpfQ1ZHTUtPY3hfbGxFQlVCRFNKeGxoUjdvUmZyT1RSWkJVOVB0cjRmcFUzOTJVWlZNY29zdkNzT1BRU0RIQ3B0VW1DTXVTNEgxSjgwSHhnTk1EUng4c1dMTWVZQVUyZ29LM1E?oc=5", "source_name": "Stock Titan", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "LNAI: Lunai Bioworks Inc. Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTE5Ednl5WFdkZ1ZaUjhKN095aUU1NG5BaDZreW01ZUpZNWxEQ21NYnRHQ3VydG8wMUhCVEJieWlmWTJXRHVQTUIxU1BR?oc=5", "source_name": "Stocktwits", "published_at": "2025-10-02T17:05:32+00:00", "published_display": "02 Oct 2025 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (RENB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE01TmNEeWhraklFbHJrMFlhVzZVWG1nUFpfYjFjeGRMdEpkalc5UjlZOUQwNWFZSTBubmtSXzVxSVU4WHlQUGZBdkVNbnhkZVpta1FhdGVGMml4Zw?oc=5", "source_name": "MarketBeat", "published_at": "2023-08-12T13:10:26+00:00", "published_display": "12 Aug 2023 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "$Lunai Bioworks (LNAI.US)$", "summary": "An investor expresses confidence in Lunai Bioworks (LNAI.US), stating that buyers will return and the stock will build momentum for a future run-up. The comment suggests an optimistic outlook for the company's stock performance. This short post is part of the moomoo Community fee", "url": "https://www.moomoo.com/community/feed/lunai-bioworks-lnai-us-no-worries-buyera-will-be-back-116762015301637", "source_name": "Moomoo", "published_at": "2026-06-17T22:39:45", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks touts defense revenue, neurology pipeline, lawsuit", "summary": "Lunai Bioworks' CEO has provided an update on the company's progress, highlighting its first revenue-generating U.S. defense contract through BioSymetrics, advancements in its Augusta AI neurology platform for epilepsy, Parkinson's, and Alzheimer's, and ongoing litigation against", "url": "https://www.stocktitan.net/news/LNAI/lunai-bioworks-ceo-letter-to-lu406oewjx95.html", "source_name": "Stock Titan", "published_at": "2026-06-17T22:39:45", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Lunai Bioworks Inc. Reports Material Event", "summary": "Lunai Bioworks Inc. (LNAI) filed an 8-K report detailing a material event, specifically the issuance of a letter to shareholders on June 17, 2026. This letter outlines the company's strategic advancements in biodefense and precision neurology, highlighted by a revenue-generating ", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-7f77a3d39d0e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:32:08", "published_display": "17 Jun 2026 20:32", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit", "summary": "Lunai Bioworks (LNAI) announced its first revenue-generating, multi-year U.S. defense collaboration with BioSymetrics for AI-enabled chemical threat assessment. The company also filed for expedited discovery in a lawsuit alleging naked short selling, citing evidence of 29.6 milli", "url": "https://www.tradingview.com/news/tradingview:4fcf7208c6092:0-lunai-bioworks-secures-first-revenue-defense-contract-files-expedited-discovery-in-naked-shorting-suit/", "source_name": "TradingView", "published_at": "2026-06-17T20:10:10", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/lunai-bioworks-ceo-letter-shareholders-131500365.html", "source_name": "PR Newswire", "published_at": "2026-06-17T13:15:00+00:00", "published_display": "17 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) Stock Soars 81% on Nasdaq Compliance Restoration", "summary": "Lunai Bioworks (LNAI) shares surged over 80% in after-hours trading after Nasdaq officially recognized the company's return to compliance with the $1.00 minimum bid price rule. While this restores their listing, the company now enters a strict one-year monitoring period where fal", "url": "https://blockonomi.com/lunai-bioworks-lnai-stock-soars-81-on-nasdaq-compliance-restoration/", "source_name": "Blockonomi", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNAI Stock Sees Volatile Spike As Traders Zero In On Risk", "summary": "Lunai Bioworks Inc Com (LNAI) stock experienced a volatile spike, trading up by 74.6% due to favorable biotech innovation news, despite weak financials. The company shows minimal revenue, significant operating losses, and a poor balance sheet, making it a high-risk, high-volatili", "url": "https://www.timothysykes.com/news/lunai-bioworks-inc-com-lnai-news-2026_06_17/", "source_name": "www.timothysykes.com", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNAI Stock Explodes On Volume As Traders Target Volatility", "summary": "Lunai Bioworks Inc (LNAI) stock surged by 61.16% on high volume, driven by positive sentiment and momentum trading despite poor fundamentals. The company reported minimal revenue, significant losses, and negative equity, making it a speculative play for short-term traders targeti", "url": "https://stockstotrade.com/news/lunai-bioworks-inc-com-lnai-news-2026_06_17/", "source_name": "StocksToTrade", "published_at": "2026-06-17T13:42:08", "published_display": "17 Jun 2026 13:42", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock jumps after Nasdaq bid-price compliance filing", "summary": "Lunai Bioworks shares surged after Nasdaq confirmed the company's compliance with the $1 minimum bid-price rule, a crucial step for maintaining its listing. Despite this, Lunai remains under a one-year Nasdaq panel monitor and faces ongoing capital needs, reporting a significant ", "url": "https://ts2.tech/en/lunai-bioworks-stock-jumps-after-nasdaq-bid-price-compliance-filing/", "source_name": "TechStock\u00b2", "published_at": "2026-06-17T12:42:08", "published_display": "17 Jun 2026 12:42", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | Lunai Bioworks Surges 151.66% Pre-Market", "summary": "Lunai Bioworks saw a significant surge of 151.66% in pre-market trading, driven by the announcement of an exclusive licensing agreement for its lead gene therapy program, LNAI-201, with Takeda Pharmaceutical. This agreement targets rare neurological genetic disorders, providing a", "url": "https://www.moomoo.com/news/post/71648509/trending-stocks-today-lunai-bioworks-surges-151-66-pre-market", "source_name": "Moomoo", "published_at": "2026-06-17T08:13:47", "published_display": "17 Jun 2026 08:13", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) Stock Is Trending Overnight \u2014 Here's Why It Spiked Nearly 81% In After-Hours Session", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdlNEOHpoV1dsMU5ESFZxUmMweDhaa0dRdnVYWXBWUW9wb0lyWWVXRVhZaXB6eTBuTXBmWk5kUU1UbzhoTFItMTQ2dnZ2MWI0TG5MLVVCbG1mSzBxWlV0UkNjbHAwRzNpNHBMM3VRejBlOXhvdWpuVlRILXVLSjZFXzRCNk4tRzA1Z1V3cjBIb2FXZUVqWG1wUkpkSTE4V3VKSTBWMXAybXdrZWJrXzBrUUIzZExLOS1qNVpUVERKX19NNlQtWkdZN05pMmRYVzd6Yzg0V0NjSzFyaGF1cVFvS2RhbDBqSzg?oc=5", "source_name": "Sahm", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Ord Shs (LNAI) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Lunai Bioworks Ord Shs (LNAI), presenting a list of major institutional shareholders and their shareholdings, including changes in their positions. Key shareholders like RS Group ApS and Lakysa Ventures, Inc. are hi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lnai/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T03:40:47", "published_display": "17 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS INC (LNAI) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE9aWEYwQTFNSTF6S1IzV1Z3VmRVMVNERVAwd3Vsdmw1LXNPUnN0b3NHM1VFNmlFNVUzdFVtcHhudEN0aF9YT25TSnBQVXRPSFZqX1o5dzJld0dnVXl3VWUyTllWbGM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-17T00:20:49+00:00", "published_display": "17 Jun 2026 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai regains Nasdaq $1.00 bid-price compliance; one-year Panel monitoring imposed", "summary": "Lunai Bioworks (LNAI) has successfully regained compliance with Nasdaq's minimum $1.00 bid-price rule. As a result, the company will be subject to a mandatory one-year monitoring period by the Nasdaq Panel. During this monitoring period, if Lunai again violates the bid-price rule", "url": "https://www.tradingview.com/news/tradingview:c4b2c2190a296:0-lunai-regains-nasdaq-1-00-bid-price-compliance-one-year-panel-monitoring-imposed/", "source_name": "TradingView", "published_at": "2026-06-16T20:03:26", "published_display": "16 Jun 2026 20:03", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) back in bid compliance but under 1-year Nasdaq monitor", "summary": "Lunai Bioworks (LNAI) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, as confirmed by Nasdaq. The company will now be under a mandatory one-year monitoring period, during which any future non-compliance with the bid price rule will result i", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-8f8d1ba38ff9.html", "source_name": "Stock Titan", "published_at": "2026-06-16T19:59:25", "published_display": "16 Jun 2026 19:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Inc Stock Short Interest Rises to 62.94%", "summary": "Lunai Bioworks Inc (LNAI) saw its short interest increase to 62.94% of the float on May 15th, representing a 50.51% rise from April 30th. This means 2,489,634 shares were held short, and it would take an estimated 1.0 days for short sellers to cover their positions. Institutional", "url": "https://www.quiverquant.com/news/Lunai+Bioworks+Inc+Stock+Short+Interest+Rises+to+62.94%25", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T13:28:00", "published_display": "09 Jun 2026 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks partners with BrainStorm on neurology drug discovery", "summary": "Lunai Bioworks' subsidiary BioSymetrics has partnered with BrainStorm Therapeutics to identify and validate new treatments for neurological diseases, focusing initially on rare genetic epilepsies and neurodegenerative conditions like Parkinson's disease. The collaboration leverag", "url": "https://m.uk.investing.com/news/stock-market-news/lunai-bioworks-partners-with-brainstorm-on-neurology-drug-discovery-93CH-4702676?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-28T15:38:47", "published_display": "28 May 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI and human brain organoids join forces on Parkinson's, rare epilepsy", "summary": "Lunai Bioworks, through its subsidiary BioSymetrics, and BrainStorm Therapeutics have launched a collaboration to discover and validate therapeutic targets for neurological diseases like Parkinson's and rare genetic epilepsies. This partnership leverages AI target discovery, huma", "url": "https://www.stocktitan.net/news/LNAI/lunai-bioworks-and-brain-storm-therapeutics-launch-foundation-funded-yancj4z23x6l.html", "source_name": "Stock Titan", "published_at": "2026-05-28T14:10:25", "published_display": "28 May 2026 14:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration", "summary": "Lunai Bioworks and BrainStorm Therapeutics are collaborating to discover and develop novel therapies for neurological diseases, including Parkinson's and rare genetic epilepsies. The partnership, supported by a grant from the LouLou Foundation, combines BioSymetrics' AI-driven ta", "url": "https://www.prnewswire.com/news-releases/lunai-bioworks-and-brainstorm-therapeutics-launch-foundation-funded-parkinsons-and-rare-epilepsy-ai-discovery-collaboration-302784369.html", "source_name": "PR Newswire", "published_at": "2026-05-28T13:10:25", "published_display": "28 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pretax income of Lunai Bioworks, Inc. \u2013 LS:A42CL6", "summary": "This article displays the pretax income for Lunai Bioworks, Inc. (A42CL6), a biotechnology company listed on the Lang & Schwarz Tradecenter. The specific financial values are not provided within the snippet, but the article indicates it is a financial data point for the company. ", "url": "https://www.tradingview.com/symbols/LS-A42CL6/financials-income-statement/pretax-income/", "source_name": "TradingView", "published_at": "2026-05-28T11:10:25", "published_display": "28 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks, Inc. Cash Flow \u2013 LS:A42CL6", "summary": "This article provides key cash flow information for Lunai Bioworks, Inc. (A42CL6), indicating a free cash flow of -888.77K EUR for Q3 2026 and -6.68M EUR for the full year 2025, with operating cash flow also at -6.68M EUR for 2025. It presents a historical overview of cash from o", "url": "https://www.tradingview.com/symbols/LS-A42CL6/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-28T11:10:25", "published_display": "28 May 2026 11:10", "sentiment": "negative", "sentiment_pct": 16, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Company Profile & Introduction", "summary": "This document is a placeholder for the company profile and introduction of Lunai Bioworks. It indicates that further details about the company will be provided within this section.", "url": "https://www.moomoo.com/stock/LNAI-US/company?chain_id=Name1K9-3FXPhg.1kqk680&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A61,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Ffeed%2F106423782735877%22%7D", "source_name": "Moomoo", "published_at": "2026-05-26T23:40:51", "published_display": "26 May 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks, Inc. Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of Lunai Bioworks Inc.'s SEC filings and other financial documents. It includes various forms such as 10-K (Annual Report) and 10-Q (Quarterly Report), investor presentations, and event transcripts dating back to 2014. The information is", "url": "https://www.tradingview.com/symbols/BOATS-LNAI/documents/", "source_name": "TradingView", "published_at": "2026-05-24T19:40:23", "published_display": "24 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock", "summary": "A federal judge in Delaware has granted Lunai Bioworks, Inc.'s motion for expedited discovery to identify \"John Doe\" defendants involved in alleged \"naked\" short-selling of the company's common stock. This action seeks to hold those responsible accountable for securities fraud an", "url": "https://www.prnewswire.com/news-releases/federal-judge-orders-expedited-discovery-to-identify-john-doe-defendants-naked-short-sellers-of-lunai-common-stock-302779803.html", "source_name": "PR Newswire", "published_at": "2026-05-22T13:39:33", "published_display": "22 May 2026 13:39", "sentiment": "positive", "sentiment_pct": 81, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Announces 1-for-8 Reverse Stock Split", "summary": "Lunai Bioworks (LNAI) announced a 1-for-8 reverse stock split of its common shares, effective May 22, 2026, to restore compliance with Nasdaq's minimum bid requirement. This action will reduce outstanding shares from approximately 36.3 million to 4.5 million, with proportional ad", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2065173/lunai-bioworks-announces-1-for-8-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-05-21T13:41:04", "published_display": "21 May 2026 13:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock falls after reverse split announcement", "summary": "Lunai Bioworks Inc. (NASDAQ:LNAI) shares dropped 12.6% after announcing a 1-for-8 reverse stock split set to take effect on May 22, 2026. This move aims to increase the stock price to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The reverse sp", "url": "https://www.investing.com/news/stock-market-news/lunai-bioworks-stock-falls-after-reverse-split-announcement-93CH-4701556", "source_name": "Investing.com", "published_at": "2026-05-21T09:41:04", "published_display": "21 May 2026 09:41", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks to implement 1-for-8 reverse stock split", "summary": "Lunai Bioworks announced a 1-for-8 reverse stock split of its common stock, effective May 21, 2026. The company's ticker symbol \"LUNA\" will remain unchanged, but the CUSIP number will change to 55042D209. The reverse stock split aims to increase the per-share trading price to mee", "url": "https://www.msn.com/en-us/money/topstocks/lunai-bioworks-to-implement-1-for-8-reverse-stock-split/ar-AA23EOJs", "source_name": "MSN", "published_at": "2026-05-20T15:40:15", "published_display": "20 May 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks stock falls after reverse split announcement By Investing.com", "summary": "Lunai Bioworks Inc. (NASDAQ:LNAI) shares dropped 12.6% after announcing a 1-for-8 reverse stock split set to take effect on May 22, 2026. This action is intended to increase the stock price to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The r", "url": "https://ng.investing.com/news/stock-market-news/lunai-bioworks-stock-falls-after-reverse-split-announcement-93CH-2521616", "source_name": "Investing.com Nigeria", "published_at": "2026-05-20T14:34:00", "published_display": "20 May 2026 14:34", "sentiment": "negative", "sentiment_pct": 14, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) plans 1-for-8 reverse split to meet Nasdaq price rule", "summary": "Lunai Bioworks (NASDAQ: LNAI) announced a 1-for-8 reverse stock split, effective May 22, 2026, to regain compliance with Nasdaq's minimum bid price rule of $1.00 per share. This action will reduce outstanding shares from approximately 36.3 million to 4.5 million, with fractional ", "url": "https://www.stocktitan.net/sec-filings/LNAI/8-k-lunai-bioworks-inc-reports-material-event-4d2e5500620a.html", "source_name": "Stock Titan", "published_at": "2026-05-20T13:40:15", "published_display": "20 May 2026 13:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPUGRUTlJSd3dUSm1YS0JPZDNKVHlmMzVJdlVKUklaTW40czd0RFhSZVltRHo1MUpjT1JFTjVyYnBQZmoxclRqSHhWVFEzOWp1VE1EM01LYWJndVQ1LUpyQzJrNDR0ZVdpbUMtNlFRdldjalllX0p3ZnByVlVrcTF1Qml6MHpGSENZcnl3dnVBTTQtSnFzQ1FleGNLY01NbV96TS1CQThWaw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks: Fiscal Q3 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lunai-bioworks-fiscal-q3-earnings-210410094.html", "source_name": "Associated Press", "published_at": "2026-05-15T21:04:10+00:00", "published_display": "15 May 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks shareholders approve reverse stock split and meeting adjournment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdW1HazRIRGJoaTlxclJvYXpyNTRCNDJYLU5vVTlZaHhTTFlTUTR6VEJwUlRaV0YtRjhzeEwwdjZkRF90SjhlY0xGdkFEa0lZUTBXUXVfVkY5MEZHRG5CRzVaN1U3U2lxc1lsUlYxMzhCbUwzX1UyS2hmaGZNVmFUTjVENWx2T3lfaWNNb0x6UjJsaDFyUzd3cU84WHFNYXdDNVZKV25ZQlBnZVBDUEJfTlI1YVg4aXNRUFJQVnZvSzR3OGFuMDFFQ00yZE9xU0hh?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) wins shareholder approval for reverse stock split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVk5tUG0zaFBaMDJEV080NXl3S2ZfWHp1RDE4LWhMY19LMldHc3B0NW1ubG80T2NiQ1p3RDhSTEMwZjQxNlhZamhFOTlaSnZhU1dlSlUzU3BHTW1aZjZaVUx3aTZqTHlWbmQwc1BaaVRPcEhnT1dLekx3bnR2RGNBajIwVWlGUUtXa0NoRXFZZ3FtUHg1ZTJrd2xwb0MwOTVBRWF4ZkVkcmg4RWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) warns of Nasdaq delisting risk after MVLS shortfall", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOOWRKbVloZ05ZQ1pEb21Gb0YwejZVWkcxZlEtei1RT0FBTktsSi1JREZtS1puXzZEQnVNZ1p0V0xTOVVsM050UnVyVzhqdjNzVjZiNUNmUWFjRElZbHhhSENycTFfVTZGUFA3VEZVQl8tZm1BU2JBaEFwVmNYU0twelBPQ2N5TXV6RVc2ZnhDd1BNRVYwZDhVWTRiX2lzOW5VbEdoZUxSR19qb1ltaG5Pa0c3SGowUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer\u2019s Disease", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oncotelic-therapeutics-announces-closing-strategic-123000748.html", "source_name": "GlobeNewswire", "published_at": "2026-05-06T12:30:00+00:00", "published_display": "06 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lunai-bioworks-completes-20-million-133500592.html", "source_name": "PR Newswire", "published_at": "2026-05-04T13:35:00+00:00", "published_display": "04 May 2026 13:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) issues $20M preferred to acquire CNS patents, aid Nasdaq equity test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQY1hZTk9VQzdYbEhuOWlMWVRPeG1JWFFoc21ndmRmNXQ2Mm1CczBLcmRLVUFoREFPT256UVhkSVZBTzg2Ump6bE5mZk5meE9nby1MdEtQYjVHVDVBWkkzYWlEempQVC1qSEcwamlwNjdwMkV4UmdBOUcxZi0xV01KYmtDbjlDRXlRNGt6dmJfaGxYRnFwajlHSUd0N01qUDhCc0tqeThTMFFVZzA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) files proxy supplement; Reverse Split on ballot", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPc29tM0g5RnhLQWNPWlM4QVd4Nmd1dloyYV93U2R2bXMtVFJHQ0ZUSUNLUkFoQlZidl9JUWRpajVxdFI0TDhLdXF5WUV5NGM3bU41MGkycVd1TmNYT3ZBWExkR09RRDJENHozdlJFMWl1ZzhBUHB1c0hrZTVKQmtEMTZpby1waDZBeVhvLU5aamxtX1BRdjNiNTI1ano0d2RGWF94MkRDU3NMajROZG52SDVB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) moves special vote to May 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQV2E0MVJkT1l1RDl3b3doQmRuTEVheUhvMEliNEg2UXFCdUxoNHhKa0tuVDFMa3hiME8ybjhJVjRiODFwUFNnNDZ3bHpleXN2SkNiQ3l4MHhBWi1sUENYMTNacnJDSHZlT09MczhqaElhX2tnTGRLSVJEUlZEbDVYQWN6YVgya2FqaTJ6cWRlX3BZWU91ZHl1Z3BCbURUZjRIOE9hcE9fTEVXN1k?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships", "summary": "", "url": "https://finance.yahoo.com/news/lunai-bioworks-nasdaq-lnai-geneial-131000127.html", "source_name": "PR Newswire", "published_at": "2026-04-15T13:10:00+00:00", "published_display": "15 Apr 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (LNAI) seeks approval for wide-range reverse stock split to support Nasdaq listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxObG42eGlPbTI5OEZ4cTN4TV9QYWFKT2tmVE91YVVhcThlVmpQODNvbWNfSC1sRkhsTlg1VjE2eXB3TTVVSUxYZjUybi1aNElvaDFlaTJnOFE2LXNENGMwTFBUOXhlSlFzMERHMm5kT3FrdnBPa1FPVmtIem03VWJ3QW9Gejl5dmhhMWd0R2dCdjZ3SW8yV3JpN242b0pOZTZhdVJTYVhjcTYyUlo0bVNqVDlTWmF6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq moves to delist Lunai Bioworks (LNAI) after 30 days under $1", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNSi0xSDVad292bTNBQjZUZnUwN0o4NkNJZFEyNGxnVFh2cUVmYWNJNDZmYXB0T1RQN3Y0VGU5cEFBcmNfN2dvWVJTdGx0TlFVWUFrM1JkT1VBQW9ETFp0YTBxN0RyVE1VRlVIa2NWYmRsaTVRNGFvc2tDSDdvejJkTGIxLUN2eEJ6ZlJ0QXBSSmxvV3B0OS15TGRwTUpzczZrU3lrZmdtNTlIVXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI firm Lunai Bioworks targets 30M with poorly treated Alcohol Use Disorder", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQb2xDNV91Snl6WmZIclh0cDRWN0pGaFdSWXEtOURjZXJDUV8wc3FOWW00UmppRDYzaUh0WGdqX2hfdHRCYlV5eEw5WW9vUmQ3bE9OVXpfQ1ZHTUtPY3hfbGxFQlVCRFNKeGxoUjdvUmZyT1RSWkJVOVB0cjRmcFUzOTJVWlZNY29zdkNzT1BRU0RIQ3B0VW1DTXVTNEgxSjgwSHhnTk1EUng4c1dMTWVZQVUyZ29LM1E?oc=5", "source_name": "Stock Titan", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LNAI: Lunai Bioworks Inc. Latest Stock Price, Analysis, News and Trading Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSkFVX3lxTE5Ednl5WFdkZ1ZaUjhKN095aUU1NG5BaDZreW01ZUpZNWxEQ21NYnRHQ3VydG8wMUhCVEJieWlmWTJXRHVQTUIxU1BR?oc=5", "source_name": "Stocktwits", "published_at": "2025-10-02T17:05:32+00:00", "published_display": "02 Oct 2025 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lunai Bioworks (RENB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE01TmNEeWhraklFbHJrMFlhVzZVWG1nUFpfYjFjeGRMdEpkalc5UjlZOUQwNWFZSTBubmtSXzVxSVU4WHlQUGZBdkVNbnhkZVpta1FhdGVGMml4Zw?oc=5", "source_name": "MarketBeat", "published_at": "2023-08-12T13:10:26+00:00", "published_display": "12 Aug 2023 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 96, "total_relevant": 52, "sentiment_summary": {"positive": 15, "negative": 7, "neutral": 30, "score": 54, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 18.15, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 4.89, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.75, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 3.78, "latest_week": "2026-06-19", "one_week_move": 56.8, "four_week_move": 67.3, "twelve_week_move": 14.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.442386, "market_dynamics_buy_signal": false, "relative_strength": -67.807047, "fair_value_gap": -95.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.6829, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+56.8% over one week, +67.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 13}, {"label": "PR Newswire", "count": 6}, {"label": "TradingView", "count": 5}, {"label": "Market source", "count": 5}, {"label": "Moomoo", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Blockonomi", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 7}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 10}, {"label": "Regulatory and legal", "count": 5}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+56.8% over one week, +67.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "$Lunai Bioworks (LNAI.US)$"}], "updated_at": "2026-06-22T20:50:48.332067+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}